Gianpiero Landolfi
Overview
Explore the profile of Gianpiero Landolfi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andreoli L, Gerardi M, Gerosa M, Rozza D, Crisafulli F, Erra R, et al.
RMD Open
. 2024 Apr;
10(2).
PMID: 38663885
Objectives: To investigate pregnancy outcomes in women with autoimmune rheumatic diseases (ARD) in the Italian prospective cohort study P-RHEUM.it. Methods: Pregnant women with different ARD were enrolled for up to...
2.
Perniola S, Alivernini S, Gremese E, Landolfi G, Carrara G, Iagnocco A, et al.
Rheumatology (Oxford)
. 2024 Feb;
64(2):526-532.
PMID: 38364299
Objective: This post-hoc analysis was carried out on data acquired in the longitudinal Sonographic Tenosynovitis Assessment in RheumaToid arthritis patiEnts in Remission (STARTER) study. Our primary aim was to determine...
3.
Scirocco C, Ferrigno S, Andreoli L, Fredi M, Lomater C, Moroni L, et al.
Lupus Sci Med
. 2023 Oct;
10(2).
PMID: 37848262
Introduction: Data concerning SARS-CoV-2 in patients affected by SLE are contradicting.The aim of this study was to investigate disease-related differences in COVID-19 prognosis of patients affected by rheumatic diseases before...
4.
De Angelis R, Ferri C, Giuggioli D, Bajocchi G, Dagna L, Bellando-Randone S, et al.
RMD Open
. 2023 Mar;
9(1).
PMID: 36868782
Objective: To describe demographic, clinical and laboratory features of systemic sclerosis sine scleroderma (ssSSc) in a large multicentre systemic sclerosis (SSc) cohort. Methods: Data involving 1808 SSc patients from Italian...
5.
Zanetti A, Carrara G, Landolfi G, Rozza D, Chighizola C, Alunno A, et al.
Clin Exp Rheumatol
. 2022 Mar;
40(11):2038-2043.
PMID: 35260224
Objectives: To investigate differences in coronavirus disease 2019 (COVID-19) mortality between patients with rheumatic musculoskeletal diseases (RMD) and the general population in Italy. Methods: We analysed the data from the...
6.
Ugarte-Gil M, Alarcon G, Izadi Z, Duarte-Garcia A, Reategui-Sokolova C, Clarke A, et al.
Ann Rheum Dis
. 2022 Feb;
81(7):970-978.
PMID: 35172961
Aim: To determine characteristics associated with more severe outcomes in a global registry of people with systemic lupus erythematosus (SLE) and COVID-19. Methods: People with SLE and COVID-19 reported in...
7.
Ditto M, Parisi S, Landolfi G, Borrelli R, Realmuto C, Finucci A, et al.
RMD Open
. 2021 Sep;
7(3).
PMID: 34489323
Background: The close relationship between joints and gut inflammation has long been known and several data suggest that dysbiosis could link spondyloarthritis (SpA) to inflammatory bowel diseases (IBD). The introduction...
8.
Scire C, Carrara G, Zanetti A, Landolfi G, Chighizola C, Alunno A, et al.
Clin Exp Rheumatol
. 2020 Jul;
38(4):748-753.
PMID: 32723435
Objectives: Italy was one of the first countries significantly affected by the coronavirus disease 2019 (COVID-19) epidemic. The Italian Society for Rheumatology promptly launched a retrospective and anonymised data collection...
9.
Vita N, Landolfi G, Basle A, Platsaki S, Lee J, Waldron K, et al.
Sci Rep
. 2016 Dec;
6:39065.
PMID: 27991525
Bacteria are thought to avoid using the essential metal ion copper in their cytosol due to its toxicity. Herein we characterize Csp3, the cytosolic member of a new family of...
10.
Conte E, Landolfi G, Vincelli G, Stefan A, Hochkoeppler A
Biotechnol Lett
. 2011 Apr;
33(9):1815-21.
PMID: 21516313
Two systems for the co-expression of proteins in Escherichia coli were designed and constructed. The first system relies on the new vector, pGOOD, which is compatible with ColE1-type plasmids and...